ceftobiprole
Selected indexed studies
- Ceftobiprole. (, 2006) [PMID:39418404]
- Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia. (N Engl J Med, 2023) [PMID:37754204]
- Ceftobiprole medocaril. (Rev Esp Quimioter, 2022) [PMID:35488820]
_Worker-drafted node — pending editorial review._
Connections
ceftobiprole is a side effect of
Sources
- Ceftobiprole. (2006) pubmed
- Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia. (2023) pubmed
- Ceftobiprole medocaril. (2022) pubmed
- Ceftobiprole medocaril for the treatment of pneumonia. (2023) pubmed
- Ceftobiprole Medocaril Sodium. (2024) pubmed
- Ceftobiprole for the treatment of pneumonia. (2019) pubmed
- Ceftobiprole: a clinical view. (2021) pubmed
- Ceftobiprole: pharmacokinetics and PK/PD profile. (2019) pubmed
- Ceftobiprole Medocaril: A New Fifth-Generation Cephalosporin. (2025) pubmed
- Ceftobiprole Medocaril Sodium. (2024) pubmed